CANY
VCEL icon

Caxton Associates (New York)’s Vericel Corp VCEL Stock Holding History

Caxton Associates (New York)’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,480
Closed -$493K – 602
2024
Q1 		$493K Buy
+9,480
New +$415K 0.03% 324
2021
Q2 		– Sell
-3,869
Closed -$215K – 622
2021
Q1 		$215K Buy
+3,869
New +$175K 0.02% 360

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Caxton Associates (New York)'s VCEL Position: Q2 2024 in Review

Caxton Associates (New York) sold out of Vericel Corp (VCEL) in Q2 2024, closing a stake of 9,480 shares — an estimated $493K sold.

Caxton Associates (New York) first reported a position in VCEL in Q1 2021 and held it in 2 quarters. The position peaked at $493K in Q1 2024. 261 funds tracked by Wall St. Rank hold VCEL as of Q2 2024.

  • Caxton Associates (New York) reported no remaining Vericel Corp position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 9,480 Vericel Corp shares in Q2 2024, an estimated $493K.
  • Caxton Associates (New York) first reported a position in Vericel Corp in Q1 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s Vericel Corp position peaked at $493K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.